This inventor holds 4 USPTO granted patents. Top assignees: Apoteksvarucentralen Vitrum Ab, Kabi Pharmacia Aktiebolag, Kabivitrum Ab. Active years: 1978-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1978-1993
Title: The Innovative Contributions of Karl A. Wretlind
Introduction
Karl A. Wretlind is a notable inventor based in Stockholm, Sweden, with a remarkable portfolio of four patents. His innovative work, particularly in the field of pharmaceuticals, has significantly contributed to advancements in medical technologies.
Latest Patents
Among Wretlind's latest inventions is an emulsion for parenteral administration, specifically an iodine-containing emulsion. This innovative formulation serves as an X-ray contrast agent and comprises iodinated lipids emulsified in an aqueous phase. The emulsion is enriched with one or more amino acids, fatty acids or their salts, fat-soluble vitamins, and/or urea, all contributing to enhanced stability. Notably, this emulsion can be sterilized in an autoclave and demonstrates prolonged storage capability without breaking down. Such advancements reflect Wretlind's dedication to improving healthcare solutions.
Career Highlights
Wretlind has a rich professional background with notable roles in various prestigious organizations. He worked at Apoteksvarucentralen, Vitrum AB, and Kabi Pharmacia Aktiebolag, contributing his expertise to develop innovative healthcare products that have made a lasting impact.
Collaborations
Throughout his career, Wretlind has collaborated with distinguished colleagues, including Bengt M. Ajaxon and Stellan Ljungberg. These partnerships have played a vital role in fostering creativity and driving the success of his inventions.
Conclusion
Karl A. Wretlind stands out as a prominent inventor whose contributions to pharmaceutical innovations continue to influence the field. His latest patents exemplify a commitment to improving patient care through advanced medical technologies. With a strong foundation of collaboration and professional experience, Wretlind's future endeavors promise to yield even greater advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile